227 related articles for article (PubMed ID: 37897083)
1. Gut microbiota-derived short chain fatty acids act as mediators of the gut-brain axis targeting age-related neurodegenerative disorders: a narrative review.
Guo B; Zhang J; Zhang W; Chen F; Liu B
Crit Rev Food Sci Nutr; 2023 Oct; ():1-22. PubMed ID: 37897083
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of short-chain fatty acid production by gut microbiota in neurodegenerative disorders.
Yadav S; Dwivedi A; Tripathi A; Tripathi AK
Nutr Res; 2022 Oct; 106():72-84. PubMed ID: 36152586
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of Short-Chain Fatty Acids Derived from Gut Microbiota in Alzheimer's Disease.
Qian XH; Xie RY; Liu XL; Chen SD; Tang HD
Aging Dis; 2022 Jul; 13(4):1252-1266. PubMed ID: 35855330
[TBL] [Abstract][Full Text] [Related]
4. The role of short-chain fatty acids in microbiota-gut-brain communication.
Dalile B; Van Oudenhove L; Vervliet B; Verbeke K
Nat Rev Gastroenterol Hepatol; 2019 Aug; 16(8):461-478. PubMed ID: 31123355
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota and short chain fatty acids partially mediate the beneficial effects of inulin on metabolic disorders in obese ob/ob mice.
Guo J; Zhang M; Wang H; Li N; Lu Z; Li L; Hui S; Xu H
J Food Biochem; 2022 May; 46(5):e14063. PubMed ID: 35128673
[TBL] [Abstract][Full Text] [Related]
6. Short-chain fatty acids: Important components of the gut-brain axis against AD.
Huang Y; Wang YF; Miao J; Zheng RF; Li JY
Biomed Pharmacother; 2024 Jun; 175():116601. PubMed ID: 38749177
[TBL] [Abstract][Full Text] [Related]
7. Functional roles of the microbiota-gut-brain axis in Alzheimer's disease: Implications of gut microbiota-targeted therapy.
Zhong SR; Kuang Q; Zhang F; Chen B; Zhong ZG
Transl Neurosci; 2021 Jan; 12(1):581-600. PubMed ID: 35070442
[TBL] [Abstract][Full Text] [Related]
8. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases.
Ashique S; De Rubis G; Sirohi E; Mishra N; Rihan M; Garg A; Reyes RJ; Manandhar B; Bhatt S; Jha NK; Singh TG; Gupta G; Singh SK; Chellappan DK; Paudel KR; Hansbro PM; Oliver BG; Dua K
Chem Biol Interact; 2022 Dec; 368():110231. PubMed ID: 36288778
[TBL] [Abstract][Full Text] [Related]
9. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
[TBL] [Abstract][Full Text] [Related]
10. Short-chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?
Peng K; Xia S; Xiao S; Yu Q
J Gastroenterol Hepatol; 2022 Sep; 37(9):1710-1718. PubMed ID: 35906780
[TBL] [Abstract][Full Text] [Related]
11. Dietary Fiber and Microbiota Metabolite Receptors Enhance Cognition and Alleviate Disease in the 5xFAD Mouse Model of Alzheimer's Disease.
Zhou Y; Xie L; Schröder J; Schuster IS; Nakai M; Sun G; Sun YBY; Mariño E; Degli-Esposti MA; Marques FZ; Grubman A; Polo JM; Mackay CR
J Neurosci; 2023 Sep; 43(37):6460-6475. PubMed ID: 37596052
[TBL] [Abstract][Full Text] [Related]
12. Mannan oligosaccharide attenuates cognitive and behavioral disorders in the 5xFAD Alzheimer's disease mouse model via regulating the gut microbiota-brain axis.
Liu Q; Xi Y; Wang Q; Liu J; Li P; Meng X; Liu K; Chen W; Liu X; Liu Z
Brain Behav Immun; 2021 Jul; 95():330-343. PubMed ID: 33839232
[TBL] [Abstract][Full Text] [Related]
13. Dietary fructose-induced gut dysbiosis promotes mouse hippocampal neuroinflammation: a benefit of short-chain fatty acids.
Li JM; Yu R; Zhang LP; Wen SY; Wang SJ; Zhang XY; Xu Q; Kong LD
Microbiome; 2019 Jun; 7(1):98. PubMed ID: 31255176
[TBL] [Abstract][Full Text] [Related]
14. Potential roles of gut microbiota and microbial metabolites in Parkinson's disease.
Zheng SY; Li HX; Xu RC; Miao WT; Dai MY; Ding ST; Liu HD
Ageing Res Rev; 2021 Aug; 69():101347. PubMed ID: 33905953
[TBL] [Abstract][Full Text] [Related]
15. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication.
Silva YP; Bernardi A; Frozza RL
Front Endocrinol (Lausanne); 2020; 11():25. PubMed ID: 32082260
[TBL] [Abstract][Full Text] [Related]
16. Short-chain fatty acids-producing probiotics: A novel source of psychobiotics.
Cheng Y; Liu J; Ling Z
Crit Rev Food Sci Nutr; 2022; 62(28):7929-7959. PubMed ID: 33955288
[TBL] [Abstract][Full Text] [Related]
17. The role of short-chain fatty acids (SCFAs) in regulating stress responses, eating behavior, and nutritional state in anorexia nervosa: protocol for a randomized controlled trial.
Quagebeur R; Dalile B; Raes J; Van Oudenhove L; Verbeke K; Vrieze E
J Eat Disord; 2023 Oct; 11(1):191. PubMed ID: 37884972
[TBL] [Abstract][Full Text] [Related]
18. Dietary neoagarotetraose extends lifespan and impedes brain aging in mice via regulation of microbiota-gut-brain axis.
Li T; Yang S; Liu X; Li Y; Gu Z; Jiang Z
J Adv Res; 2023 Oct; 52():119-134. PubMed ID: 37085001
[TBL] [Abstract][Full Text] [Related]
19. Associations of gut microbiota, dietary intake, and serum short-chain fatty acids with fecal short-chain fatty acids.
Yamamura R; Nakamura K; Kitada N; Aizawa T; Shimizu Y; Nakamura K; Ayabe T; Kimura T; Tamakoshi A
Biosci Microbiota Food Health; 2020; 39(1):11-17. PubMed ID: 32010539
[TBL] [Abstract][Full Text] [Related]
20. Gut-brain axis: Focus on gut metabolites short-chain fatty acids.
Guo C; Huo YJ; Li Y; Han Y; Zhou D
World J Clin Cases; 2022 Feb; 10(6):1754-1763. PubMed ID: 35317140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
